From April 1, 2023 to June 30, 2023, the company has repurchased 89,196 shares, representing 0.35% for CAD 0.43 million. With this, the company has completed the repurchase of 276,495 shares, representing 1.1% for CAD 0.91 million under the buyback announced on September 19, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.99 CAD | 0.00% | +3.57% | +62.27% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+62.27% | 159M | |
+40.24% | 734B | |
+32.90% | 591B | |
-7.09% | 350B | |
+14.61% | 315B | |
+0.80% | 276B | |
+14.04% | 238B | |
+8.71% | 206B | |
-6.38% | 204B | |
+4.25% | 161B |
- Stock Market
- Equities
- CPH Stock
- News Cipher Pharmaceuticals Inc.
- Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on September 19, 2022.